Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
University of Pennsylvania
National Institutes of Health Clinical Center (CC)
Advaxis, Inc.
ZielBio, Inc.
Queensland Centre for Gynaecological Cancer
University Health Network, Toronto
M.D. Anderson Cancer Center
Quest PharmaTech Inc.
Ontario Clinical Oncology Group (OCOG)
Edward-Elmhurst Health System
National Institutes of Health Clinical Center (CC)
Queensland Centre for Gynaecological Cancer
National Institutes of Health Clinical Center (CC)
Pierian Biosciences
AIO-Studien-gGmbH
Santa Maria Biotherapeutics
Edward-Elmhurst Health System
Novartis
Celldex Therapeutics
University of Miami
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)